Literature DB >> 20463318

In vivo and in vitro development of S- and M-cones in rat retina.

Blanca Arango-Gonzalez1, Arnold Szabó, German Pinzon-Duarte, Akos Lukáts, Elke Guenther, Konrad Kohler.   

Abstract

PURPOSE: Organ cultures of the rodent retina could provide a powerful tool in the study of cone development and differentiation. Previous attempts, however, have failed to show M-cone development in organ cultures of the mouse and rat retina. This study mimicked the in vivo dynamics of S- and M-cone development in a culturing approach for the postnatal rat retina.
METHODS: Retinas of Brown Norway rats were collected at different developmental ages (postnatal day [P]0-P270) to study cone development in vivo. For culturing, the retinas were prepared from P0 to P2 animals and allowed to develop in organ culture for 2 to 15 days. Subsequently, opsin expression was analyzed immunohistochemically and morphometrically.
RESULTS: In control retinas, S-opsin was already expressed at birth, whereas M-opsin was detected after P4. The maximum density of S-opsin-positive cones was reached at P10 (∼17,000 cells/mm(2)) and of M-opsin-positive cones, at P12 (∼14,000 cells/mm(2)). The number of both cone types decreased gradually thereafter to ∼1,000 S-opsin cones/mm(2) and ∼4,000 M-opsin cones/mm(2) in the adult. In culture, both cone types developed with dynamics of appearance comparable to those in vivo, with a peak density of ∼12,300 cones/mm(2) for S-opsin and ∼7,500 cones/mm(2) for M-opsin labeling.
CONCLUSIONS: These results in rat retina showed for the first time that cone development and expression dynamics can be mimicked in organ culture. With this experimental approach, it will be possible to evaluate aspects of cone development under controlled experimental conditions and to elucidate factors crucial for proper cone differentiation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20463318     DOI: 10.1167/iovs.09-4741

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  6 in total

1.  Inhibition of SULT4A1 expression induces up-regulation of phototransduction gene expression in 72-hour postfertilization zebrafish larvae.

Authors:  Frank Crittenden; Holly Thomas; Cheryl M Ethen; Zhengliang L Wu; Dongquan Chen; Timothy W Kraft; John M Parant; Charles N Falany
Journal:  Drug Metab Dispos       Date:  2014-02-19       Impact factor: 3.922

2.  Melanopsin ganglion cells extend dendrites into the outer retina during early postnatal development.

Authors:  Jordan M Renna; Deepa K Chellappa; Christopher L Ross; Maureen E Stabio; David M Berson
Journal:  Dev Neurobiol       Date:  2015-01-08       Impact factor: 3.964

3.  Histological Evaluation of Diabetic Neurodegeneration in the Retina of Zucker Diabetic Fatty (ZDF) Rats.

Authors:  Klaudia Szabó; Anna Énzsöly; Bulcsú Dékány; Arnold Szabó; Rozina I Hajdú; Tamás Radovits; Csaba Mátyás; Attila Oláh; Lenke K Laurik; Gábor M Somfai; Béla Merkely; Ágoston Szél; Ákos Lukáts
Journal:  Sci Rep       Date:  2017-08-21       Impact factor: 4.379

4.  Efficient Ocular Delivery of VCP siRNA via Reverse Magnetofection in RHO P23H Rodent Retina Explants.

Authors:  Merve Sen; Marco Bassetto; Florent Poulhes; Olivier Zelphati; Marius Ueffing; Blanca Arango-Gonzalez
Journal:  Pharmaceutics       Date:  2021-02-06       Impact factor: 6.321

5.  Pharmacological Inhibition of the VCP/Proteasome Axis Rescues Photoreceptor Degeneration in RHOP23H Rat Retinal Explants.

Authors:  Merve Sen; Oksana Kutsyr; Bowen Cao; Sylvia Bolz; Blanca Arango-Gonzalez; Marius Ueffing
Journal:  Biomolecules       Date:  2021-10-16

6.  Pharmacokinetics of Pullulan-Dexamethasone Conjugates in Retinal Drug Delivery.

Authors:  Eva Kicková; Amir Sadeghi; Jooseppi Puranen; Shirin Tavakoli; Merve Sen; Veli-Pekka Ranta; Blanca Arango-Gonzalez; Sylvia Bolz; Marius Ueffing; Stefano Salmaso; Paolo Caliceti; Elisa Toropainen; Marika Ruponen; Arto Urtti
Journal:  Pharmaceutics       Date:  2021-12-21       Impact factor: 6.321

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.